289 related articles for article (PubMed ID: 31451931)
41. Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.
Kaemmerer D; Sänger J; Arsenic R; D'Haese JG; Neumann J; Schmitt-Graeff A; Wirtz RM; Schulz S; Lupp A
Oncotarget; 2017 Oct; 8(52):89958-89969. PubMed ID: 29163802
[TBL] [Abstract][Full Text] [Related]
42. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
[TBL] [Abstract][Full Text] [Related]
43. Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).
Manfredi S; Walter T; Baudin E; Coriat R; Ruszniewski P; Lecomte T; Laurenty AP; Goichot B; Rohmer V; Roquin G; Cojocarasu OZ; Lombard-Bohas C; Lepage C; Morcet J; Cadiot G
Endocrine; 2017 Sep; 57(3):504-511. PubMed ID: 28664309
[TBL] [Abstract][Full Text] [Related]
44. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract][Full Text] [Related]
45. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
Shi H; Zhang Q; Han C; Zhen D; Lin R
BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F; Tachezy M; Effenberger K; von Loga K; Zander H; Marx A; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Oncol; 2011 Aug; 104(2):140-5. PubMed ID: 21520098
[TBL] [Abstract][Full Text] [Related]
47. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
48. Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.
Nakayama Y; Wada R; Yajima N; Hakamada K; Yagihashi S
Pancreas; 2010 Nov; 39(8):1147-54. PubMed ID: 20717067
[TBL] [Abstract][Full Text] [Related]
49. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Rizzo FM; Vesely C; Childs A; Marafioti T; Khan MS; Mandair D; Cives M; Ensell L; Lowe H; Akarca AU; Luong T; Caplin M; Toumpanakis C; Krell D; Thirlwell C; Silvestris F; Hartley JA; Meyer T
Br J Cancer; 2019 Feb; 120(3):294-300. PubMed ID: 30636773
[TBL] [Abstract][Full Text] [Related]
50. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.
Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML
Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143
[TBL] [Abstract][Full Text] [Related]
51. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Hasegawa S; Kobayashi N; Tokuhisa M; Goto A; Takano S; Takada Y; Kaneta T; Mori R; Matsuyama R; Endo I; Yamanaka S; Nakajima A; Inoue T; Ichikawa Y
Digestion; 2017; 96(1):13-20. PubMed ID: 28609761
[TBL] [Abstract][Full Text] [Related]
52. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
53. Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors.
Herrera-Martínez AD; Gahete MD; Sánchez-Sánchez R; Alors-Perez E; Pedraza-Arevalo S; Serrano-Blanch R; Martínez-Fuentes AJ; Gálvez-Moreno MA; Castaño JP; Luque RM
Clin Transl Gastroenterol; 2018 Oct; 9(10):196. PubMed ID: 30297816
[TBL] [Abstract][Full Text] [Related]
54. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
55. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
[TBL] [Abstract][Full Text] [Related]
56. The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours.
Hussain F; Wang J; Ahmed R; Guest SK; Lam EW; Stamp G; El-Bahrawy M
Cytokine; 2010 Feb; 49(2):134-40. PubMed ID: 20005738
[TBL] [Abstract][Full Text] [Related]
57. Associations between Single Nucleotide Polymorphisms in the Mitochondrial DNA D-Loop Region and Outcome of Gastroenteropancreatic Neuroendocrine Neoplasm.
Er LM; Li Y; Er L; Wu M; Zheng XL; Guo ZJ; Yuan HF
Ann Clin Lab Sci; 2018 May; 48(3):333-337. PubMed ID: 29970437
[TBL] [Abstract][Full Text] [Related]
58. PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
Lee Y; Kim SJ; Park HD; Park EH; Huang SM; Jeon SB; Kim JM; Lim DS; Koh SS
Oncogene; 2010 Jan; 29(1):56-67. PubMed ID: 19784070
[TBL] [Abstract][Full Text] [Related]
59. Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors.
Oktay E; Yalcin GD; Ekmekci S; Kahraman DS; Yalcin A; Degirmenci M; Dirican A; Altin Z; Ozdemir O; Surmeli Z; Diniz G; Ayhan S; Bulut G; Erdogan A; Uslu R
J BUON; 2019; 24(2):779-790. PubMed ID: 31128036
[TBL] [Abstract][Full Text] [Related]
60. Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.
Wu H; Zhu L; Zhang H; Shi X; Zhang L; Wang W; Xue H; Liang Z
PLoS One; 2015; 10(2):e0116803. PubMed ID: 25679210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]